Stockchase Opinions

Terry Shaunessy iShares MSCI Emerging Markets XEC-T PAST TOP PICK Dec 09, 2020

(A Top Pick Jan 24/20, Up 12%) Owns a lot of this. Two-thirds of this are mega-cap Chinese and Korean stocks, including Alibaba, Tencent and Samsung which rank among the biggest in the world by market cap. Yet, they aren't in indexes like EAFE. Eventually he thinks these big names will be migrated into the regular global ETFs. For now, XEC is the way to play them. Growth will come from Asia.

$29.870

Stock price when the opinion was issued

E.T.F.'s
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

PAST TOP PICK
(A Top Pick Oct 05/18, Up 5%) He's been positive on emerging markets. There's a shift in production out of China to some of these countries. There are stocks from South Korea, Japan, Philippines and India amogst others.
TOP PICK
Some people say that Chinese problems might spill over. He sees it as production chains moving out of China into emerging markets. These economies look good, and multiples in these markets are reasonable. A very broad index. China is 30%, India 10% and a world wide spread. It’s recently had a good run.
BUY
An emerging markets ETF with good coverage internationally. It’s performed quite well recently. The multiples are more reasonable and growth potential is okay.
TOP PICK

This is big-cap China, Taiwan and Korea. Tencent, Alibaba and Samsung are in this fund. This is where he sees growth in the future. It is very volatile from time to time but it's not as volatile as it seems. Yield is 2.85%.

TOP PICK
He hadn't anticipated the impact of the coronavirus. It has a big Chinese content that can do well in the long-run but he wouldn't be in a rush to buy in right now. Stocks are very cheap in emerging markets and they are not affected by the virus.
COMMENT
It's a good place to start, low-cost and liquid. Long-term this is set up for a good return. But this is very broad-based, overweighting the winners of recent years. He prefers specific
BUY
Generally, likes the emerging markets. They'll lead the way in the vaccine recovery, and benefit from a weaker US dollar. Its largest weighting is in China, with lots of very strong tech names. EM is probably underowned right now. A good hold for the next 2-3 years.
HOLD
Great. A core holding. Low cost, pure beta play. Bullish on EM. They've underperformed for the last 11 years, and they're set for a long period of outperformance. The issue is that it's still 40% tech, and he's moving away from tech. Look at DEM instead, as it overweights EM companies that have higher dividends and a higher quality tilt. DEM is diversified, with a yield of about 4.5%, PE ratio of around 10.
BUY
Tilted portfolios towards developed and emerging international. Best returns will come from here.